Pathophysiology and pharmacologic treatment of acute spinal cord injury.
about
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord InjuryFOXO3a/p27kip1 expression and essential role after acute spinal cord injury in adult rat.Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injuryImatinib enhances functional outcome after spinal cord injuryInhibition of GADD34, the stress-inducible regulatory subunit of the endoplasmic reticulum stress response, does not enhance functional recovery after spinal cord injuryMethylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury RegistryTherapeutic effect of apocynin through antioxidant activity and suppression of apoptosis and inflammation after spinal cord injury.HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injuryInhibition of CXCR1 and CXCR2 chemokine receptors attenuates acute inflammation, preserves gray matter and diminishes autonomic dysreflexia after spinal cord injury.Beneficial effect of the traditional chinese drug shu-xue-tong on recovery of spinal cord injury in the rat.Neuroprotective effect of combining tanshinone IIA with low-dose methylprednisolone following acute spinal cord injury in rats.Role of early surgical decompression of the intradural space after cervical spinal cord injury in an animal modelPreconditioning of isoflurane on spinal cord ischemia can increase the number of inducible nitric oxide synthase-expressing motor neurons in ratThe effects of intraspinal microstimulation on spinal cord tissue in the rat.Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.Loss of hsp70.1 Decreases Functional Motor Recovery after Spinal Cord Injury in MiceOmega-conotoxin MVIIC attenuates neuronal apoptosis in vitro and improves significant recovery after spinal cord injury in vivo in ratsEfficacy of some non-conventional herbal medications (sulforaphane, tanshinone IIA, and tetramethylpyrazine) in inducing neuroprotection in comparison with interleukin-10 after spinal cord injury: A meta-analysis.Nontraumatic acute paraplegia associated with cervical disk herniation.Curcumin Stimulates Proliferation of Spinal Cord Neural Progenitor Cells via a Mitogen-Activated Protein Kinase Signaling Pathway.Biochanin A reduces drug-induced p75NTR expression and enhances cell survival: a new in vitro assay for screening inhibitors of p75NTR expressionPlasticity of the injured human spinal cord: insights revealed by spinal cord functional MRI.Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats.The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury.Protective effects of Batroxobin on spinal cord injury in rats.Hyperbaric oxygen therapy improves local microenvironment after spinal cord injury.SCO-spondin derived peptide NX210 induces neuroprotection in vitro and promotes fiber regrowth and functional recovery after spinal cord injuryNanomedicine for treating spinal cord injury.Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.New Prophylactic and Therapeutic Strategies for Spinal Cord InjuryDevelopmental and injury-induced expression of alpha1beta1 and alpha6beta1 integrins in the rat spinal cord.Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.Batroxobin protects against spinal cord injury in rats by promoting the expression of vascular endothelial growth factor to reduce apoptosis.Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.Effects of Olig2-overexpressing neural stem cells and myelin basic protein-activated T cells on recovery from spinal cord injurySetting the stage for functional repair of spinal cord injuries: a cast of thousands.Paraplegic mice are leading to new advances in spinal cord injury research.Bridging the lesion-engineering a permissive substrate for nerve regenerationClinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy.Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury.
P2860
Q26748907-D6E8B143-39D6-4175-89E4-59166178312AQ27863427-1479EC03-72AA-46E3-A01D-8686A4D0112EQ28085174-6E5D71BD-DDD7-4D39-83AB-7053DB6B259FQ28480537-2416465F-C10B-4F5F-B1C4-F39D63164D36Q28544841-0ED4D7E7-E430-4146-9EBB-080A263CD3F7Q28607659-EEF9DEB6-B398-4942-BD3E-32A2CB097F64Q33598338-71320093-E048-4380-8598-4E21EFB52E77Q33634585-09AAE383-F1A2-4147-908F-E54342437D6EQ33704944-1E586EFD-97EC-4CE8-870A-BE701FA37131Q33720710-6303EE6E-ED1F-4D3A-93B4-E9C0A03B48F6Q33723851-ACEEB874-FF2A-4FFD-9E86-38F923215094Q33811439-04B28218-6972-4C12-B745-EA46DC921E59Q33861692-41E5C3D2-4C51-4079-8E94-623CF7E564B7Q33872292-2EF72F7B-9813-4336-85BC-ED26E2C4F81BQ33898347-C3CDB377-911E-4092-912F-BA291D33F611Q33988350-992EFF69-0BA1-45E6-9837-3A5803A613BFQ34028851-9F026AB7-76EE-49BF-8943-4079E2C10D30Q34041359-DC943768-F36D-44FB-96D3-28D7808395D7Q34240421-C5ADE6D4-3D41-4B01-9703-866FA3382CA1Q34289734-8B8B8339-3C91-4B05-BB98-DB6A93DD3B2BQ34421141-C59208B1-5817-4CD9-9D42-89FFC00EEE24Q34429420-D424B455-A012-41AE-8CF2-44844C0B5BF7Q34500255-C9CCE0A7-737B-4794-B699-C9671A376DF7Q34811137-ED0EBB0D-1725-4E77-8457-0BE3928533A0Q34818586-057F22AB-A0C1-4C6B-AA17-11708CB4D41CQ35046949-41AB5C9D-36C7-46ED-9E93-EDEF006B378BQ35131462-8B194E30-90BA-442D-BFA6-7BD7DC07444EQ35216746-B97FEF97-5103-4E47-9F7D-1066F862CC91Q35222071-AA79305B-5CBB-4C58-B3C4-691D215BE4B7Q35332802-B0613A68-B87F-427A-9BDD-16A0679ADD65Q35628789-F3231B02-2BA1-4BD3-A4C4-5E86FEFC225DQ35729623-2871BE29-D7D4-4683-92FC-ECC6524EFC19Q35754210-40F91BCA-D2F0-4141-8E91-D2E6357D4F82Q35901019-4B1995EC-25A1-4A99-9A84-42997410E9D1Q35913786-B02FE386-A81C-4F92-B611-510CD3B1E7EBQ36020714-7664EF0A-C279-45C3-82D2-A657B6DD8B9EQ36089058-B01CAA69-DD30-48AB-BC12-D0D06C7D9830Q36345120-F02B81E3-8ED5-45A9-8D2E-E79C243FF428Q36415316-996C651F-673E-489B-BA76-75DEB999AC18Q36416677-BF34B785-0C8F-4E3F-9817-0C23C290F779
P2860
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
@ast
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
@en
type
label
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
@ast
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
@en
prefLabel
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
@ast
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
@en
P2093
P1433
P1476
Pathophysiology and pharmacologic treatment of acute spinal cord injury.
@en
P2093
Alexander R Vaccaro
Brian K Kwon
John Beiner
Jonathan N Grauer
Wolfram Tetzlaff
P304
P356
10.1016/J.SPINEE.2003.07.007
P577
2004-07-01T00:00:00Z